Press What’s news at AbelsonTaylor Group
Select category
Moving Into 2024
Applying his background in pharmacology, Jeff Berg, President of AbelsonTaylor Group, discusses a particularly exciting use of AI in drug discovery that is tackling one of biology’s biggest challenges – predicting the 3D shape of proteins and designing them from scratch. Read more at https://www.pharmalive.com/healthcare-agency-roundtable-2024-moving-into-2025/
Media Contact:
Recent Posts
Social Media Marketing Trends 2025 Report
Thenetworkone just released its annual industry resource on social media trends, including expert insights from AT Group’s Associate Director of Engagement...
In the News Read more Social Media Marketing Trends 2025 ReportAn Indie POV on the Omnicom-Interpublic Merger
AT Group President Jeff Berg recently joined MM+M’s Jack O’Brien to discuss the future of the medical advertising industry in...
Read Press Read more An Indie POV on the Omnicom-Interpublic MergerHow will pharma marketers crack the AI code in 2025?
MM+M January 3, 2025 In the article, “How will pharma marketers crack the AI code in 2025?” AbelsonTaylor Group’s Amy...
In the News Read more How will pharma marketers crack the AI code in 2025?Connect with us
Find out what's top of mind for the people reimagining health and wellness advertising.